This article summarizes the most significant insider buying and selling activities reported for US stocks on Tuesday, October 8, 2024.
Top Insider Buys:
• FrontView REIT, Inc. (NYSE:FVR): Alyeska Investment Group, a significant shareholder in FrontView REIT, Inc., has increased its stake in the company. The investment group purchased 810,810 shares worth approximately $15.5 million at an average price of $19.11. The transactions were executed on October 3, 2024, through multiple acquisitions of 135,135 shares each. This substantial investment demonstrates Alyeska’s continued confidence in the real estate investment trust’s future prospects.
• Eton Pharmaceuticals , Inc. (NASDAQ:): Opaleye Management Inc., a major shareholder in Eton Pharmaceuticals, has bolstered its position in the company through a series of stock purchases totaling approximately $434,000. The transactions occurred over several days, with share prices ranging between $6.771 and $7.2235. These purchases were made on behalf of both Opaleye’s managed fund, Opaleye, L.P., and a separately managed account, reflecting the investment manager’s ongoing commitment to the healthcare sector.
• Mueller Water Products, Inc. (NYSE:NYSE:): Brian C. Healy, a director at Mueller Water Products, made a notable purchase of the company’s stock on October 7. Healy acquired 1,125 shares at an average price ranging from $21.91 to $21.99, for a total investment of $24,738. This transaction was executed in accordance with a Rule 10b5-1 trading plan, which Healy had previously adopted on May 15, 2024, demonstrating a pre-planned approach to his stock acquisitions.
• Tile Shop (NASDAQ:) Holdings, Inc. (NASDAQ:TTSH): Investment entities associated with Pleasant Lake Partners have increased their stake in Tile Shop Holdings, a company specializing in home furnishings and equipment retail. The entities, including Pleasant Lake Onshore Feeder Fund LP, Fund 1 Investments, LLC, and Pleasant Lake Partners LLC, collectively purchased shares valued at over $78,000. The acquisitions took place in two separate transactions on October 4 and October 8, 2024, with share prices ranging between $6.4202 and $6.4332.
• AngioDynamics Inc. (NASDAQ:): James C. Clemmer, President and CEO of AngioDynamics, has made a significant purchase of the company’s stock. On October 7, Clemmer acquired 20,000 shares at a weighted average price of $6.03 per share, totaling an investment of $120,600. The transaction, which involved purchases at prices ranging from $5.95 to $6.08, has increased Clemmer’s total ownership in the medical device company to 681,582 shares.
Top Insider Sells:
• Trade Desk, Inc. (NASDAQ:): Jeffrey Terry Green, President and CEO of Trade Desk, Inc., has sold a substantial amount of the company’s Class A Common Stock. The total value of the transactions amounted to $45,052,383, with share prices ranging from $111.75 to $113.35. The sales were executed over two days, October 4 and October 7, 2024, at various weighted average prices.
• MoonLake Immunotherapeutics (NASDAQ:MLTX): Executives of Biotechnology Value Fund L P and related entities have divested a significant number of shares in MoonLake Immunotherapeutics. On October 4, 2024, they sold a total of 2,053,000 Class A Ordinary Shares at a price of $50.0016 per share, amounting to $100,003,200. The selling entities include Biotechnology Value Fund II L P, BVF Partners L P/IL, and other related parties.
• Apple Inc. (NASDAQ:): Luca Maestri, Senior Vice President and Chief Financial Officer of Apple Inc., has sold a considerable portion of the company’s stock. On October 4, 2024, Maestri sold 59,305 shares at an average price of $226.52, totaling approximately $13.43 million. The transaction was conducted under a prearranged Rule 10b5-1 trading plan, which Maestri had adopted on November 11, 2023.
• Boston Scientific Corp (NYSE:BSX): Joseph Michael Fitzgerald, Executive Vice President and Group President of Cardiology at Boston Scientific Corp, has sold a large number of shares. Fitzgerald disposed of 132,527 shares at an average price of approximately $85.00, with sales occurring in a range from $85.00 to $85.01 per share. The total value of the shares sold amounted to $11,264,887. This transaction was part of a pre-established trading plan.
• Boston Scientific Corporation (NYSE:NYSE:): Michael F. Mahoney, Chairman, President, and CEO of Boston Scientific Corporation, has conducted significant stock transactions. On October 7, Mahoney sold 162,777 shares for a total value exceeding $13.7 million, with individual sale prices ranging from $84.31 to $84.94. Additionally, Mahoney acquired 111,886 shares through stock option exercises, valued at approximately $1.88 million, with prices between $16.31 and $17.26. These transactions were executed under a pre-established Rule 10b5-1 trading plan.
Staying informed about insider buying and selling activities can provide valuable insights for investors. These transactions may offer clues about a company’s future prospects, as insiders often have unique knowledge about their company’s operations and outlook. However, it’s important to remember that insider transactions can occur for various reasons and should not be the sole basis for investment decisions. Always consider a wide range of factors and conduct thorough research before making any investment choices.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
